Research and development teams amass huge quantities of complex data which, if exploited correctly, can be a useful information source to improve decision-making and drive innovation.
It is estimated that one in five human cancers involve RAS mutations. Although once considered undruggable, this blog looks at recent advances in RAS inhibitors and emerging therapies.
We are in the midst of a therapeutic revolution, according to the authors of a recent review article in Frontiers in Bioengineering and Biotechnology. They were commenting on the rapid expansion of...
Plastics found in common consumer products are traditionally made from synthetic polymers derived from petroleum. Biopolymers created from biomass are generated from renewable sources, which fixes...
Lipid nanoparticles are key therapeutic vehicles in the pharmaceutical industry, as well as medical imaging, cosmetics, nutrition and more. Discover how lipid nanoparticles are applied in cancer...
